- Bevacizumab 1% eye drops
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Bevacizumab 1% eye drops | Start Date 11-07-2016 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Ocular
- Form
- Eye drops
- Ontology Form/Route
- solutiondrops.ophthalmic
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- S01LA08
Code | Start Date | End Date |
---|---|---|
32906011000001107 | 11-07-2016 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Bevacizumab | Based on Ingredient Substance | 10 mg | 1 ml |
Name
Bevacizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10
Strength and UOM (Dmr)
1
Parent Products
-
VTMBevacizumab
-
VMP(Current) Bevacizumab 1% eye drops
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
4 ml |